| KALA Snapshot | |
|---|---|
| Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $19,236,400 | Price to Sales | 0.00 |
| Earnings per Share | $-17.3500 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $6.5900 |
| 52 Week High | $1.157 |
| 52 Week Low | $2.702 |
| 50-Day Moving Average | $0.0421 |
| 200-Day Moving Average | $-0.158 |
| All data are from Alpha Vantage as of today. For more infomation on KALA see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search